Abstract: an anaerobic, spore-forming enteropathogen, is less studied in animals than in humans despite its importance in One Health. We evaluated occurrence, diversity, circulation, and virulence in French Equidae ( = 100) after their necropsy in northwestern France, from 2019 to 2021. We systematically recovered all cecal contents and any watery intestinal contents. We isolated strains, determined their toxin gene profile by PCR, and established their PCR-ribotype according to the WEBRIBO database. We also performed free toxin detection. Twenty-seven Equidae were positive for and 20 had a toxigenic strain, including one animal co-colonized by a non-toxigenic strain. Toxigenic isolates belonged to eight already described ribotypes: (i) 078 and 126 (toxin genes of wild-type size: ), (ii) 005, 012, 020, AI-53, and FR227 (), and (iii) 017 (). Non-toxigenic isolates were of ribotypes 009, 035, and 439. Ribotypes 017 and 009 were predominant ( = 5). In two cases, Equidae of the same premises shared the same ribotype, either 020 or 009. Free toxins were detected in four animals: they displayed signs of diarrhea and a of ribotype 126 ( = 1) or 017 ( = 3) as the only detected enteropathogen, suggesting a infection (CDI). Three of them had received antibiotics. Two had died from an entero-toxic infection, for which ribotype 017 was the only identified cause. French Equidae displayed common pathogenic and ribotype 017 was highly virulent. These findings are of concern from a One Health perspective.IMPORTANCE, a major enteropathogen widely disseminated in the environment, is a One Health issue. Animals are raising concern as human contamination sources. Equidae are in close contact with humans and also develop -antibiotic and healthcare-associated CDIs. The systematic survey of Equidae necropsied from 2019 to 2021 in the leading horse breeding region in France revealed that 20% harbored pathogenic strains. These belonged to clinically important ribotypes, raising the possibility of cross-species, zoonotic or anthropo-zoonotic transmission. Free toxins, which are rarely tested in animals, were detected in four animals with signs of diarrhea and a toxigenic as the only identified enteropathogen, suggesting CDI. In two of them, ribotype 017 was the only identified cause of entero-toxic disease and death. French Equidae could play a role in the dissemination of pathogenic and notably ribotype 017. They should be surveilled carefully from a One Health perspective.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study investigated the presence, diversity, and virulence of Clostridioides difficile (C. difficile), a significant bacterial pathogen, in horses in northwestern France.
The research identified toxigenic strains of C. difficile in equidae and examined their potential role in disease and public health from a One Health perspective.
Introduction and Background
Clostridioides difficile is an anaerobic, spore-forming bacterium that causes intestinal infections (enteropathogen).
While well studied in humans, less is known about its presence and impact in animals, particularly horses (equidae).
The One Health concept links human, animal, and environmental health, emphasizing the importance of studying zoonotic pathogens like C. difficile in animals.
Horses can live in close contact with humans and may act as reservoirs or vectors for transmission of pathogenic bacteria.
Objectives
Evaluate the occurrence and diversity of C. difficile strains in French equidae undergoing necropsy from 2019 to 2021 in northwestern France.
Assess the virulence of these strains by detecting toxin genes and free toxins.
Determine the potential role of horses in disseminating clinically important C. difficile strains relevant to public health.
Methods
Sample Collection:
Collected cecal contents and watery intestinal contents systematically from 100 necropsied equidae.
Bacterial Isolation:
Isolated C. difficile strains anaerobically from intestinal samples.
Molecular Characterization:
Performed PCR to determine the toxin gene profile of isolated strains.
Used PCR ribotyping and compared results with the WEBRIBO database to classify strains.
Toxin Detection:
Assessed presence of free toxins in intestinal contents to establish clinical relevance.
Key Findings
Occurrence: 27 out of 100 equidae tested positive for C. difficile, and 20 had toxigenic strains.
Strain Diversity:
Toxigenic strains belonged to eight known ribotypes, including ribotypes 078, 126, 005, 012, 020, AI-53, FR227, and notably 017.
Non-toxigenic strains were ribotypes 009, 035, and 439.
Ribotypes 017 (particularly virulent) and 009 were the most common (five each).
Same ribotype strains were found in horses from the same farm, indicating some circulation.
Toxin Activity and Disease Correlation:
Free toxins (indicating active toxin production) were detected in four horses displaying diarrhea.
These horses had either ribotype 126 or ribotype 017 as the sole enteropathogen, suggesting confirmed C. difficile infection (CDI).
Three of these animals had prior antibiotic use, a known CDI risk factor.
Two horses died from entero-toxic infections caused solely by ribotype 017.
Virulence and Public Health Concern:
Ribotype 017 showed high virulence and was confirmed as the cause of severe disease and death in some cases.
Presence of clinically important ribotypes in horses raises concerns about zoonotic or cross-species transmission.
Conclusions and Implications
Approximately 20% of necropsied horses in the study region harbored pathogenic C. difficile strains.
The identification of toxigenic and virulent ribotypes—including ribotype 017—in equidae highlights their potential role as reservoirs for pathogens relevant to human and animal health.
Horses may contribute to environmental dissemination and cross-species transmission of C. difficile.
The findings underscore the importance of surveillance and monitoring of C. difficile in animals under a One Health framework.
Routine testing for free toxins in animals with diarrhea may improve diagnosis and understanding of CDI in veterinary medicine.
Importance of the Study
Highlights the underexplored role of horses in the ecology of C. difficile.
Supports the need for integrated approaches in managing infectious diseases that affect both animals and humans.
Raises awareness of antibiotic-associated disease in horses, analogous to hospital-acquired infections in humans.
Suggests that controlling C. difficile in animals could reduce risks of zoonotic transmission and environmental contamination.
Cite This Article
APA
Petry S, Tapprest J, Maillard K, Barbut F, Duquesne F, Kozak S, Foucher N, Bernez-Romand M, Bridoux L, Poquet I.
(2025).
Clostridioides difficile in equidae necropsied in Northwestern France, between 2019 and 2021.
Microbiol Spectr, 14(2), e0216525.
https://doi.org/10.1128/spectrum.02165-25
Crobach MJT, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ. European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22 Suppl 4:S63–81.
van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, Krutova M, Norén T, Allerberger F, Coia JE, Goorhuis A, van Rossen TM, Ooijevaar RE, Burns K, Scharvik Olesen BR, Tschudin-Sutter S, Wilcox MH, Vehreschild MJGT, Fitzpatrick F, Kuijper EJ, Guideline Committee of the European Study Group on. European society of clinical microbiology and infectious diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect 27 Suppl 2:S1–S21.
Poquet I, Saujet L, Canette A, Monot M, Mihajlovic J, Ghigo JM, Soutourina O, Briandet R, Martin-Verstraete I, Dupuy B. Clostridium difficile biofilm: remodeling metabolism and cell surface to build a sparse and heterogeneously aggregated architecture. Front Microbiol 9:2084.
Rodriguez C, Taminiau B, Van Broeck J, Delmée M, Daube G. Clostridium difficile in food and animals: a comprehensive review. Adv Exp Med Biol 932:65–92.
Warriner K, Xu C, Habash M, Sultan S, Weese SJ. Dissemination of Clostridium difficile in food and the environment: significant sources of C. difficile community-acquired infection?. J Appl Microbiol 122:542–553.
Hensgens MPM, Keessen EC, Squire MM, Riley TV, Koene MGJ, de Boer E, Lipman LJA, Kuijper EJ. Clostridium difficile infection in the community: a zoonotic disease?. Clin Microbiol Infect 18:635–645.
Knetsch CW, Connor TR, Mutreja A, van Dorp SM, Sanders IM, Browne HP, Harris D, Lipman L, Keessen EC, Corver J, Kuijper EJ, Lawley TD. Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. Euro Surveill 19:20954.
Janezic S, Zidaric V, Pardon B, Indra A, Kokotovic B, Blanco JL, Seyboldt C, Diaz CR, Poxton IR, Perreten V, Drigo I, Jiraskova A, Ocepek M, Weese JS, Songer JG, Wilcox MH, Rupnik M. International Clostridium difficile animal strain collection and large diversity of animal associated strains. BMC Microbiol 14:173.
Sallé G, Guillot J, Tapprest J, Foucher N, Sevin C, Laugier C. Compilation of 29 years of postmortem examinations identifies major shifts in equine parasite prevalence from 2000 onwards. Int J Parasitol 50:125–132.
Barbut F, Day N, Bouée S, Youssouf A, Grandvoinnet L, Lalande V, Couturier J, Eckert C. Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study. Clin Microbiol Infect 25:588–594.
Ferraris L, Couturier J, Eckert C, Delannoy J, Barbut F, Butel MJ, Aires J. Carriage and colonization of C. difficile in preterm neonates: a longitudinal prospective study. PLoS One 14:e0212568.
Freeman J, Sanders I, Harmanus C, Clark EV, Berry AM, Smits WK. Antimicrobial susceptibility testing of Clostridioides difficile: a dual-site study of three different media and three therapeutic antimicrobials. Clin Microbiol Infect 31:1011–1017.
Le Monnier A, Candela T, Mizrahi A, Bille E, Bourgeois-Nicolaos N, Cattoir V, Farfour E, Grall I, Lecointe D, Limelette A. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals. J Hosp Infect 129:65–74.
Knight DR, Kullin B, Androga GO, Barbut F, Eckert C, Johnson S, Spigaglia P, Tateda K, Tsai PJ, Riley TV. Evolutionary and genomic insights into Clostridioides difficile sequence type 11: a diverse zoonotic and antimicrobial-resistant lineage of global one health importance. mbio 10:e00446-19.
Agnoletti F, Arcangeli G, Barbanti F, Barco L, Brunetta R, Cocchi M, Conedera G, D’Este L, Drigo I, Spigaglia P, Mazzolini E. Survey, characterization and antimicrobial susceptibility of Clostridium difficile from marine bivalve shellfish of North Adriatic Sea. Int J Food Microbiol 298:74–80.
Tkalec V, Viprey V, Davis G, Janezic S, Sente B, Devos N, Wilcox M, Davies K, Rupnik M, COMBACTE-CDI consortium. Clostridioides difficile positivity rate and PCR ribotype distribution on retail potatoes in 12 European countries, January to June 2018. Euro Surveill 27:2100417.
Diniz AN, Coura FM, Rupnik M, Adams V, Stent TL, Rood JI, de Oliveira CA Jr, Lobato FCF, Silva ROS. The incidence of Clostridioides difficile and Clostridium perfringens netF-positive strains in diarrheic dogs. Anaerobe 49:58–62.
Oliveira Júnior CA, Silva ROS, Lage AP, Coura FM, Ramos CP, Alfieri AA, Guedes RMC, Lobato FCF. Non-toxigenic strain of Clostridioides difficile Z31 reduces the occurrence of C. difficile infection (CDI) in one-day-old piglets on a commercial pig farm. Vet Microbiol 231:1–6.
Forero AJ, Muñoz M, Camargo M, Soto-De León SC, Ríos-Chaparro DI, Birchenall C, Pinilla D, Pardo JM, Josa DF, Patarroyo MA, Ramírez JD. High frequency of toxigenic Clostridium difficile and Clostridium perfringens coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogotá, Colombia. Gut Pathog 11:27.
Alves F, Castro R, Pinto M, Nunes A, Pomba C, Oliveira M, Silveira L, Gomes JP, Oleastro M. Molecular epidemiology of Clostridioides difficile in companion animals: genetic overlap with human strains and public health concerns. Front Public Health 10:1070258.
Gerding DN, Sambol SP, Johnson S. Non-toxigenic Clostridioides (Formerly Clostridium) difficile for prevention of C. difficile infection: from bench to bedside back to bench and back to bedside. Front Microbiol 9:1700.
Le Maréchal C, Gateau C, Poezevara T, Couturier J, Rouxel S, Syed Zaidi R, Houard E, Pourcher A-M, Denis M, Barbut F. Characterization of Clostridioides difficile strains isolated from manure and digestate in five agricultural biogas plants. Anaerobe 62:102180.